Replies to post #211288 on Biotech Values

[DewDiligence]

TMO acquires PTHN for $35/sh in cash—a 35% premium to Friday’s closing price:

https://finance.yahoo.com/news/thermo-fisher-scientific-acquire-patheon-110000799.html

TMO has already obtained backing from PTHN’s two largest shareholders. The nominal deal value is $7.2B (including $2.0B assumption of debt).

[MadCityCyclone]

Why bother with an IPO?